Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
A
179530
vs
K
KOSPI 200
Over the past 12 months, ADBiotech Co Ltd has underperformed KOSPI 200, delivering a return of -37% compared to KOSPI 200's +125% growth.
Stocks Performance
179530 vs KOSPI 200
Performance Gap
179530 vs KOSPI 200
Performance By Year
179530 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ADBiotech Co Ltd
Glance View
ADBiotech Co Ltd makes molecular diagnostic products used to detect diseases and other biological targets. Its main products are test kits, reagents, and related lab equipment that help hospitals, laboratories, and testing distributors identify infectious diseases, genetic markers, and other conditions from patient or sample material. The company does not sell medicines; it sells the tools that let labs run tests. The company earns money by manufacturing and selling these diagnostic kits and reagents, and in some cases the instruments that support them. Its customers are medical labs, hospitals, public health and research users, and distributors that resell testing products in local markets. Like other diagnostics suppliers, it depends on repeat purchases of consumable test materials, which need to be replenished as labs keep testing. What makes ADBiotech’s business easy to understand is that it sits in the middle of the testing chain. It turns biological chemistry into packaged tests that can be used in routine lab workflows, where speed, accuracy, and ease of use matter. That makes it a specialized supplier to the healthcare testing industry rather than a broad medical company.